Abstract
Patterns of Relapse and Clinical Outcomes in Multiple Myeloma Patients after Anti-BCMA CAR T-Cell Therapy: Implications for Patient's Monitoring after CAR T-Cell Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have